# Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

> **NCT05684692** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Schwannomatosis
- Schwannomas
- Pain, Chronic

## Interventions

- **DRUG:** Siltuximab
- **DRUG:** Erenumab-Aooe
- **DRUG:** Siltuximab Matching Placebo
- **DRUG:** Erenumab-Aooe Matching Placebo

## Key facts

- **NCT ID:** NCT05684692
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-31
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05684692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05684692, "Screening Trial for Pain Relief in Schwannomatosis (STARFISH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05684692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*